American Association for Cancer Research
10780432ccr110679-sup-f1_pdf_243k.pdf (243.45 kB)

Supplementary Figure 1 from MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

Download (243.45 kB)
journal contribution
posted on 2023-03-31, 16:50 authored by Nigel B. Jamieson, Douglas C. Morran, Jennifer P. Morton, Asif Ali, Euan J. Dickson, C. Ross Carter, Owen J. Sansom, T.R. Jeffry Evans, Colin J. McKay, Karin A. Oien

PDF file - 243K, Supervised average linkage clustering with centred Pearson correlation using 48 PDACs and 10 normal pancreatic samples. miRNAs are in rows with the samples in columns. The non-tumor normal pancreatic samples are on the right highlighted in green, with the tumor samples highlighted in blue. The expression color bar is shown below the dendrogram. Red indicates a miRNA expression value higher than the average expression across all samples, while blue indicates a lower expression value.



Purpose: MicroRNAs (miRNA) have potential as diagnostic and prognostic biomarkers and as therapeutic targets in cancer. We sought to establish the relationship between miRNA expression and clinicopathologic parameters, including prognosis, in pancreatic ductal adenocarcinoma (PDAC).Experimental Design: Global miRNA microarray expression profiling of prospectively collected fresh-frozen PDAC tissue was done on an initial test cohort of 48 patients, who had undergone pancreaticoduodenectomy between 2003 and 2008 at a single institution. We evaluated association with tumor stage, lymph node status, and site of recurrence, in addition to overall survival, using Cox regression multivariate analysis. Validation of selected potentially prognostic miRNAs was done in a separate cohort of 24 patients.Results: miRNA profiling identified expression signatures associated with PDAC, lymph node involvement, high tumor grade, and 20 miRNAs were associated with overall survival. In the initial cohort of 48 PDAC patients, high expression of miR-21 (HR = 3.22, 95% CI: 1.21–8.58) and reduced expression of miR-34a (HR = 0.15, 95% CI: 0.06–0.37) and miR-30d (HR = 0.30, 95% CI: 0.12–0.79) were associated with poor overall survival following resection independent of clinical covariates. In a further validation set of 24 patients, miR-21 and miR-34a expression again significantly correlated with overall survival (P = 0.031 and P = 0.001).Conclusion: Expression patterns of miRNAs are significantly altered in PDAC. Aberrant expression of a number of miRNAs was independently associated with reduced survival, including overexpression of miR-21 and underexpression of miR-34a.Summary: miRNA expression profiles for resected PDAC were examined to identify potentially prognostic miRNAs. miRNA microarray analysis identified statistically unique profiles, which could discriminate PDAC from paired nonmalignant pancreatic tissues as well as molecular signatures that differ according to pathologic features. miRNA expression profiles correlated with overall survival of PDAC following resection, indicating that miRNAs provide prognostic utility. Clin Cancer Res; 18(2); 534–45. ©2011 AACR.

Usage metrics

    Clinical Cancer Research



    Ref. manager